Evidence map›Paper›PMID 21911376›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family.

Sung Hoon Cho, Annie K Ahn, Prerna Bhargava, Chih-Hao Lee, Christine M Eischen, Owen McGuinness, Mark Boothby

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 107 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2023
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Sung Hoon ChoDepartment of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Annie K Ahn
Prerna Bhargava
Chih-Hao Lee
Christine M Eischen
Owen McGuinness
Mark Boothby
Harvard University · USVanderbilt University · USNational Jewish Health · USUniversity of Colorado Denver · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
Interdisciplinary Training in Genes and the EnvironmentT32ES016645 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI LEE, CHIH-HAO · 2008 to 2018
$4.0M
Roles of rictor in mTOR signaling, differentiation & immune memory via Akt & PKCR01HL106812 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOOTHBY, MARK R · 2011 to 2018
$3.1M
Flexibility and Commitment in Post-Effector Cd4 LymphocytesR01AI077528 · NIAID · VANDERBILT UNIVERSITY · PI BOOTHBY, MARK R · 2009 to 2013
$1.9M
Interleukin 4 Regulation of LymphocytesR01AI068149 · NIAID · VANDERBILT UNIVERSITY · PI BOOTHBY, MARK R · 2006 to 2010
$1.8M
Regulation of Myc-Mediated TumorigenesisR01CA148950 · NCI · VANDERBILT UNIVERSITY · PI EISCHEN, CHRISTINE M. · 2011 to 2015
$1.7M
Integration of Stat6, Co-regulation, and Gene ExpressionR01GM071735 · NIGMS · VANDERBILT UNIVERSITY · PI BOOTHBY, MARK R. · 2004 to 2007
$1.2M
NCI NIH HHS CA68485NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA148950NHLBI NIH HHS R01 HL106812NIAID NIH HHS AI068149NIAID NIH HHS R01 AI068149NIAID NIH HHS R01 AI077528NIDDK NIH HHS DK020593NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P60 DK020593NIEHS NIH HHS T32 ES016645NIGMS NIH HHS GM071735NIGMS NIH HHS R01 GM071735
6 · The paper itself

Abstract

Poly(ADP-ribose)polymerase (PARP)14--a member of the B aggressive lymphoma (BAL) family of macrodomain-containing PARPs--is an ADP ribosyltransferase that interacts with Stat6, enhances induction of certain genes by IL-4, and is expressed in B lymphocytes. We now show that IL-4 enhancement of glycolysis in B cells requires PARP14 and that this process is central to a role of PARP14 in IL-4-induced survival. Thus, enhancements of AMP-activated protein kinase activity restored both IL-4-induced glycolytic activity in Parp14(-/-) B cells and prosurvival signaling by this cytokine. Suppression of apoptosis is central to B-lymphoid oncogenesis, and elevated macro-PARP expression has been correlated with lymphoma aggressiveness. Strikingly, PARP14 deficiency delayed B lymphomagenesis and reversed the block to B-cell maturation driven by the Myc oncogene. Collectively, these findings reveal links between a mammalian ADP ribosyltransferase, cytokine-regulated metabolic activity, and apoptosis; show that PARP14 influences Myc-induced oncogenesis; and suggest that the PARP14-dependent capacity to increase cellular metabolic rates may be an important determinant of lymphoma pathobiology.

Indexed as

GlycolysisAMP-Activated Protein KinasesAnimalsApoptosisBiological TransportB-LymphocytesCells, CulturedEnzyme ActivationFemaleGlucoseImmunoblottingIn Situ Nick-End LabelingInterleukin-4LymphomaMaleMiceAMP-Activated Protein KinasesGlucoseInterleukin-4Parp14 protein, mousePoly(ADP-ribose) PolymerasesStat6 protein, mouseSTAT6 Transcription Factor

Identifiers

PMID21911376
PMCPMC3179111
OpenAlexW2052177327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.